Search

everythinglearnresearchcommunity

for

Search:↓

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Minoxidil improved hair growth in a child with a rare genetic disorder.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

Combined minoxidil and PRP therapy improves hair growth without affecting physical performance.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Orlistat might block the body's ability to absorb thyroid medication.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.